These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7653320)

  • 41. Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinic.
    Weizman T; Gelkopf M; Melamed Y; Adelson M; Bleich A
    Aust N Z J Psychiatry; 2004; 38(1-2):42-6. PubMed ID: 14731193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contingent reinforcement sustains post-detoxification abstinence from multiple drugs: a preliminary study with methadone patients.
    Chutuape MA; Silverman K; Stitzer M
    Drug Alcohol Depend; 1999 Mar; 54(1):69-81. PubMed ID: 10101619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Related factors and interaction on HIV/HCV co-infection of patients access to methadone maintenance treatment].
    Yao T; Feng D; Pan MH; Cheng YP; Li CX; Wang J; Feng YL; Shi J; Su T; Chen Q; Shi S; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):631-635. PubMed ID: 29860807
    [No Abstract]   [Full Text] [Related]  

  • 44. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
    Lott DC; Strain EC; Brooner RK; Bigelow GE; Johnson RE
    J Subst Abuse Treat; 2006 Sep; 31(2):187-94. PubMed ID: 16919747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    J Epidemiol Community Health; 1996 Oct; 50(5):534-7. PubMed ID: 8944860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using peer, self, and counselor ratings to evaluate treatment progress.
    Czuchry M; Dansereau DF; Sia TL; Simpson DD
    J Psychoactive Drugs; 1998; 30(1):81-7. PubMed ID: 9565211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
    Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
    Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
    Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methadone maintenance therapy outcomes in Iran.
    Noori R; Narenjiha H; Aghabakhshi H; Habibi G; Khoshkrood Mansoori B
    Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.
    Battjes RJ; Pickens RW; Brown LS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):90-6. PubMed ID: 7648291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationships between childhood abuse and neglect experience and HIV risk behaviors among methadone treatment drop-outs.
    Kang SY; Deren S; Goldstein MF
    Child Abuse Negl; 2002 Dec; 26(12):1275-89. PubMed ID: 12464301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Visual representation tools for improving addiction treatment outcomes.
    Czuchry M; Newbern-McFarland D; Dansereau DF
    J Psychoactive Drugs; 2009 Jun; 41(2):181-7. PubMed ID: 19705680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral risk factors of human immunodeficiency virus infection among intravenous drug users and implications for preventive interventions.
    Nemoto T; Brown LS; Foster K; Chu A
    AIDS Educ Prev; 1990; 2(2):116-26. PubMed ID: 2393617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of benzodiazepines and detoxification with methadone.
    Popescu G; Negrei C; Bălălău D; Ciobanu AM; Baconi D; Bălălău C
    J Med Life; 2014; 7 Spec No. 3(Spec Iss 3):133-6. PubMed ID: 25870711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methadone treatment and risk of HIV infection in drug users without legal access to clean injection equipment.
    Wietlisbach V; Meystre-Agustoni G; Martin J
    Soz Praventivmed; 1995; 40(3):183-90. PubMed ID: 7610718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand.
    van Griensvan F; Keawkungwal J; Tappero JW; Sangkum U; Pitisuttithum P; Vanichseni S; Suntharasamai P; Orelind K; Gee C; Choopanya K;
    AIDS; 2004 Jan; 18(2):295-301. PubMed ID: 15075548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progressive alliance.
    Manohar B
    J Indian Soc Periodontol; 2015; 19(6):609. PubMed ID: 26941506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.